This coauthored book traces the history of clinical labor by situating it against one hundred years of change in labor law and industrial relations in advanced economies. Melinda Cooper and Catherine Waldby, both specialists in sociology and social policy, pursue the theme of how wider dynamics in labor law, welfare regimes, and (de)industrialization influence the condition of clinical labor. In terms of method, the authors focus on discourses and practices in the life sciences as a means to generate narratives, organized by theme and chapter, that explore how ideas found in legal rulings as well as those in scholarly works on law, economics, and ethics have (de)legitimized particular sets of practices in the biomedical industry, and vice versa, over time.
global North migrate to, and are translated within, other locations-particularly those found in transitional economies such as those in India, China, and postsocialist European countries. Such a mapping richly illustrates the recent global division of clinical labor.
Divided into three parts, the book begins by addressing the question "What is clinical labor?" The authors suggest that gamete and tissue provision, gestational surrogacy, and human subject experimentation in drug trials-each often understood and defined as an altruistic and voluntary act-should be regarded as a form of work, or clinical labor, specifically because of the central role these activities play in processes of valorization in the post-Fordist economy (7). Existing conceptual and institutional frameworks in bioethics have proven inadequate for capturing the changing nature of the biomedical industry, highly adaptive as it is to bioethical regulations, and the increasingly precarious nature of clinical participation also calls for a new conceptual framework to make sense of these activities (8). Instead of presuming bioethical requirements to be a normative tool, the authors take on bioethics as a subject of analysis by considering its relations with changing labor laws and social welfare regimes through the archaeology of volenti non fit injuria.
The second question that the authors pose and attempt to answer is "How did the current condition of clinical labor come about?" The core argument in the book is that conditions surrounding clinical labor have emerged from the broader dynamics of (de)industrialization and post-Fordist transition, a process whereby a system of statutory labor protections reserved for the industrial male worker has given way to a far more precarious regime of labor outsourcing that treats workers like private contractors (18 -19) . Coinciding with this shift is the dissolution of the male breadwinner model as well as a spatial reconfiguration of the household as women undertook a mass exodus into the paid workforce from unpaid reproductive labor in the home. This change has opened up an entire contract-based and female-dominated service sector largely composed of sex/affective labor and the monetization of biological processes of reproduction. Shrinkages in employment-based social welfare and affordable health services constitute another profound transformation that has exacerbated the precariousness of workforces over the same period. These changes, the authors argue, coproduce a pool of readily available bodies, usually recruited from among the underemployed, day laborer, ex-prisoner, undocumented, and precarious classes for the assisted reproduction market, biomedical sector, and pharmaceutical industry.
The second part of the book consists of three empirical chapters, each of which respectively fleshes out the evolution of assisted reproductive technology (ART), the rise of the human fertility business, and the development of the stem cell industry. Chapters 3 and 4 examine how ideas of gender, class, and race play out in both domestic and transnational chains of assisted reproduction against a background of changing legal instruments, industrial relations, and biotechnology. While the recruitment of gamete providers is considerably shaped by consumers longing to (re)produce desired class status and mobility up the scale of whiteness, gestational surrogacy works along the line of recruiting young healthy women from less advantaged socioeconomic backgrounds. In both advanced and transitional economies, reproductive labor is a continuous form of feminized labor. These two chapters also attempt to answer the question "How did the current practices of reproductive industry and human subject research migrate to other locations?" Cooper and Waldby propose that a combination of several factors at the international level, such as the global division of labor, discrepancies in labor costs between different countries, variations in national regulations, and trends in business offshoring fueled by a neoliberal hunt for cost savings, cocreates a condition of "reproductive arbitrage," which pushes for transnationalization and outsourcing of reproductive business to countries that offer cheaper gestational labor. Domestic policies of some transitional economies that take advantage of the population's "excess fecundity" are equally significant in accounting for cross-border reproductive business (85). In chapter 5, the authors examine the condition of clinical labor in stem cell research and the regenerative medicine industry. As research into regeneration requires high volumes of human embryos, oocytes, fetal tissue, and umbilical cord blood, women again constitute the primary source for provision. Unlike those for reproductive labor, recruitment strategies for stem cell research aspire to persuade potential tissue donors with the logic of avoiding wastage, a rhetoric derived from the life-producing notion or teleological understanding of reproductive biology.
The final part focuses solely on human subjects in drug trials in the pharmaceutical industry. Chapter 6 investigates the evolution of drug trials in the United States, spotlighting developments after 1970. As a result of several changes in the postwar era, such as the rise of consumer protection in the 1950s, the 1962 Kefauver-Harris Amendments (KHA), and prohibition of prison-based experiments, the pharmaceutical industry ceased testing drugs on prisoners, public hospital patients, and employees of wartime services. Instead it began to draw potential human subjects from the precarious workforce produced by the post-Fordist transformation. At the same time, the authors differentiate two categories of precarious labor along the chain of a three-phase testing process required by the 1962 KHA. In phase 1, toxicity tests demand healthy subjects, thereby attracting participants from the same pool from which the reproductive industry recruits its clinical labor, whereas in phases 2 and 3, efficacy tests call for a source of "patient subjects" largely drawn from a class of sick and impoverished persons cocreated by shrinkages in subsidized health care and insecurities in the labor market. The term "patient subjects" thus refers to those poor patients who participate in drug tests and become experimental subjects in order to have access to health care and drugs that are otherwise unaffordable, whereas the first category of subjects participate for financial compensation. Cooper and Waldby observe that the emergence of "patient subjects" blurs the boundary between drug consumption and production as the "risk bearing bodies" simultaneously consume and produce data about the tested drug. Arguing along this line, the authors reassert that research subject recruitment is indeed a labor supply issue, yet unrecognized as such (158). Chapter 7 moves on to investigate local labor and industrial conditions that have given rise to human subject experimentation in the pharmaceutical industries of China and India. Chapter 8, the final chapter, unfolds into a consideration of the co-optation of AIDS activism, which has inspired and promoted a "democratic right to participate as non-standard subjects in drug trials" and "the right to take risks" in the user-generated drug or open-source innovation model deployed by Big Pharma companies.
Taken as a whole, this book brings together at least seven conventionally distinctive bodies of literature-namely, the history of labor and industrialization; postcolonial studies of cultural capital; the global division of labor, gender studies, biopolitics, and bioethics; and the political economy of the biomedical industry-to weave a global story of the modern formation of clinical labor. Cooper and Waldby expertly offer a comprehensive and substantial argument for why a reconceptualization of human subject experimentation as clinical labor is necessary by outlining inadequacies and challenges within existing regulation. This book is a provocative read suitable for scholars in multiple fields of the social sciences.
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